The story of how life started on Earth is one that scientists are eager to learn. Researchers may have uncovered an important detail in the plot of chapter one: an explanation of how bubbles of fat came to form the membranes of the very first cells.
A key part of the new findings, made by a team from The Scripps Research Institute in California, is that a chemical process called phosphorylation may have happened earlier than previously thought.
This process adds groups of atoms that include phosphorus to a molecule, bringing extra functions with it – functions that can turn spherical collections of fats called protocells into more advanced versions of themselves, able to be more versatile, stable, and chemically active.
Quantum traffic laws applied to the 3D streetscape of a specific kind of crystal can put the brakes on electron rush hour.
In a search for novel materials that can contain bizarre new states of matter, physicists from Rice University in the US led an experiment that forced free-roaming electrons to stay in place.
While the phenomenon has been seen in materials where electrons are constrained to just two dimensions, this is the first time it’s been observed in a three-dimensional crystal metal lattice, known as a pyrochlore. The technique gives researchers a new tool for studying the less conventional activities of plucky, charge-carrying particles.
Cancer survivor, Gail Baron Simpson, shares her personal journey to treatment success in this in-depth interview with Precision Oncology specialist and CTOAM co-founder, Alex Rolland, and Michelle Morand, Precision Cancer Medicine Advocacy specialist and CTOAM co-founder.
Please watch our short intro video to Gail’s story first! 👉 • Introduction to Gail’s Incredible Can…
After being diagnosed with a rare orphan cancer, Gail discusses her experience with navigating the challenges of standard healthcare and her decision to hire CTOAM to help integrate Precision Cancer Medicine into her cancer care – and how she was able to advocate for the right treatment and eventually find success.
Join us for an extraordinary livestream webinar, ‘Paving the Way for the Future: Learning from 4 Biostasis Cases and the Challenges and Advancements at Tomorrow Bio’ featuring esteemed speakers Dr. Emil Kendziorra and Dr. Irishikesh Santhosh from Tomorrow Biostasis GmbH. This pivotal session, scheduled for March 18th, 2024, at 7:00 PM, will delve into the latest advancements and real-world applications of biostasis, focusing on the detailed processes and outcomes associated with four distinct patient cases from 2023.
In this webinar, we will explore the intricate procedures and challenges encountered during the biostasis process, including stabilization in the face of cardiopulmonary arrest, the nuances of surgical and perfusion procedures, and the critical cooldown process for long-term storage. Our experts will unpack the innovative techniques employed, the utilization of cryoprotectant solutions, cooling techniques, and the diligent monitoring through CT scans, alongside the resolution of unforeseen technical challenges.
Each case report offers a unique glimpse into the complexities of biostasis, presenting the issues faced, such as equipment malfunctions and procedural hurdles, and the subsequent strategies for resolution or planned mitigations. Through graphical presentations on temperature, pressure, and refractive index, and detailed analyses of CT scans, attendees will gain comprehensive insights into the cutting-edge methods and equipment pivotal to biostasis.
This webinar is not just a learning opportunity but a platform for interactive discussion. We encourage all attendees to engage with our speakers through live questions, share their insights, and participate in real-time polls. Whether you’re a seasoned medical professional, an avid student of science, or simply fascinated by the potential of biostasis to preserve life, this session promises to be both enlightening and engaging.
A computational model of the more than 26 million atoms in a DNA-packed viral capsid expands our understanding of virus structure and DNA dynamics, insights that could provide new research avenues and drug targets, University of Illinois Urbana-Champaign researchers report in the journal Nature.
“To fight a virus, we want to know everything there is to know about it. We know what’s inside in terms of components, but we don’t know how they’re arranged,” said study leader Aleksei Aksimentiev, an Illinois professor of physics. “Knowledge of the internal structures gives us more targets for drugs, which tend to focus on receptors on the surface or replication proteins.”
Viruses keep their genetic material —either DNA or RNA—packaged in a hollow particle called a capsid. While the structures of many hollow capsids have been described, the structure of a full capsid and the genetic material inside it has remained elusive.
A group of researchers created a first-generation AI worm that can steal data, spread malware, and spam others via an email client to spread through multiple systems.
Researchers successfully tested this Morris II worm and published its findings using two methods.
The first UK patients received the experimental mRNA therapy – a type of immunotherapy treatment called mRNA-4359 – at Imperial College Healthcare NHS Trust as part of a phase 1/2 clinical trial. The trial aims to evaluate its safety and potential for treating melanoma, lung cancer and other ‘solid tumour’ cancers.
The treatment is designed using messenger RNA (mRNA) and works by presenting common markers of tumours to the patient’s immune system. This should help to train patients’ immune systems to recognise and fight cancer cells expressing these markers, but also potentially eliminate cells that may suppress the immune response.
